Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Accounts Payables (2020 - 2025)

Historic Accounts Payables for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $5.5 million.

  • iSpecimen's Accounts Payables rose 807.84% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year increase of 807.84%. This contributed to the annual value of $4.2 million for FY2024, which is 693.23% up from last year.
  • As of Q3 2025, iSpecimen's Accounts Payables stood at $5.5 million, which was up 807.84% from $5.0 million recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Accounts Payables registered a high of $5.5 million during Q2 2024, and its lowest value of $832678.0 during Q4 2021.
  • Its 5-year average for Accounts Payables is $3.5 million, with a median of $3.8 million in 2023.
  • Data for iSpecimen's Accounts Payables shows a peak YoY increase of 19531.98% (in 2022) and a maximum YoY decrease of 7912.63% (in 2022) over the last 5 years.
  • Over the past 5 years, iSpecimen's Accounts Payables (Quarter) stood at $832678.0 in 2021, then skyrocketed by 195.32% to $2.5 million in 2022, then skyrocketed by 59.63% to $3.9 million in 2023, then rose by 6.93% to $4.2 million in 2024, then skyrocketed by 30.74% to $5.5 million in 2025.
  • Its last three reported values are $5.5 million in Q3 2025, $5.0 million for Q2 2025, and $4.6 million during Q1 2025.